COMPOSITIONS CONTAINING AT LEAST ONE CHK 1 INHIBITOR AND AT LEASE ONE CYCLODEXTRIN ARE DISCLOSED. ALSO DISCLOSED ARE METHODS OF TREATING A CANCER OR POTENTIATING A CANCER TREATMENT WITH A COMPOSITION COMPRISING AT LEAST CHK 1 INHIBITOR AND AT LEAST ONE CYCLODEXTRIN.